European Commission approves teclistamab plus daratumumab for relapsed/refractory multiple myeloma, offering a... ecancer 16h
Protein degrader approval offers hope to relapsed multiple myeloma patients Chemistry World Magazine 1d
Blenrep clears 1st reimbursement hurdle in Korea for relapsed multiple myeloma Korea Biomedical Review 6d
J&J’s Imaavy secures expanded US approval in rare blood disorder Pharmaceutical Technology 11h Johnson and Johnson
Protein degrader approval offers hope to relapsed multiple myeloma patients Chemistry World Magazine 1d Chemistry Pharma Zenbexus All sources
Is the reported $400 billion AstraZeneca-Bristol Myers Squibb megamerger a slam dunk -- or a disaster waiting to happen? The Motley Fool 03:08 Fri, 14 Aug AstraZeneca Pharma All sources
Bristol Myers Squibb to build new plant in Houston Pharmaceutical Processing World 19:47 Thu, 13 Aug Pharma All sources
At least 1 in 4 NFL players develop CTE — and that's likely an undercount, new study finds PhillyVoice 11h CTE NFL All sources
Musk's SpaceX to build $100bn launch site in Louisiana BBC 7h Starship SpaceX Space Exploration All sources
Conspiracy theorists beware! This week's lunar eclipse shows Earth isn't flat. Here's how to prove it yourself BBC Sky at Night Magazine 2h Lunar Eclipse The Moon Astronomy All sources
Nicotine e-cigarettes help more smokers quit than conventional methods News-Medical.Net 3h Nature All sources
